You can learn about our research in the press:

• AMP SCZ and Monument Therapeutics Launches First Clinical Study of MT1988, a Novel Treatment for Cognitive Impairment Associated with Schizophrenia

• Our team discusses Hope for Young People at risk of Developing Psychosis

• Watch Dr. Cheryl Corcoran Discuss Treatment and Research for Psychosis Risk: Frontiers in Psychiatric Treatment: Psychosis Risk

• Dr. Corcoran is named exemplary psychiatrist by National Alliance on Mental Illness (NAMI) NAMICon 2022 Virtual Event Honors Mental Health Leaders

• Mount Sinai press release on the research done by Dr. Corcoran, “Speech Analysis Software Predicted Psychosis in At-Risk Patients with up to 83 Percent Accuracy, Mount Sinai Researchers Find.”

Recent Publications from Our Team:

• A novel task-based method for tracking social cognition and its association with social functioning in schizophrenia spectrum disorders: Preliminary findings

• Local chemoarchitecture explains widespread lower cortical thickness associated with clinical high risk for psychosis

• Predicting transition to psychiatric disorders in clinical high-risk for psychosis subjects using machine learning and facial features

• Abnormal speech production in veterans with bipolar disorder: Relationship to the arcuate fasciculus

• Speech and language patterns in autism: Towards natural language processing as a research and clinical tool

• Linguistic correlates of suicidal ideation in youth at clinical high-risk for psychosis

• Exploring language and cognition in schizophrenia: Insights from computational analysis

• Psychoeducation for individuals at clinical high risk for psychosis: A scoping review

• Differential Expression of Anomalous Self-Experiences in Spontaneous Speech in Clinical High-Risk and Early Course Psychosis Quantified by Natural Language Processing

• Linguistic correlates of suicidal ideation in youth at clinical high-risk for psychosis

• Development of the Brief Educational Guide for Individuals in Need (BEGIN): A psychoeducation intervention for individuals at risk for psychosis

• Psychosis-like experiences and resilience: A systematic and critical review of the literature

• Equity in Mental Health Services for Youth at Clinical High Risk for Psychosis: Considering Marginalized Identities and Stressors

• Construct validity for computational linguistic metrics in individuals at clinical risk for psychosis: Associations with clinical ratings

• A qualitative study on identity in individuals at clinical high risk for psychosis: " … Why does it have to be one thing?"

• Negative symptoms and speech pauses in youths at clinical high risk for psychosis.

• Processing speed and brain volume in individuals at clinical high-risk for psychosis with comorbid eating disorders: A brief report.

• Linking language features to clinical symptoms and multimodal imaging in individuals at clinical high risk for psychosis.

• Language as a biomarker for psychosis: A natural language processing approach.

• Self-stigma related feelings of shame and facial fear recognition in individuals at clinical high risk for psychosis: A brief report.

• A case report and first-person account of an individual at risk for psychosis who improved during the COVID-19 pandemic.

• The association between mental health stigma and face emotion recognition in individuals at risk for psychosis.